AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

HomeStock ListCentury Communities Inc

Century Communities Inc

Closed

Sector Consumer cyclical

83.73 -5.5

Overview

Share price change

24h

Current

Min

82.83

Max

88.64

Key metrics

By Trading Economics

Income

8.2M

91M

Sales

316M

1.2B

P/E

Sector Avg

11.865

38.364

EPS

2.93

Dividend yield

1.201

Profit margin

7.575

Employees

1,650

EBITDA

44M

129M

Recommendations

By TipRanks

Rating Consensus

Neutral

12 Months Forecast

+5.04 upside

Dividends

By Dow Jones

Dividend Yield

Sector avg

1.20%

1.26%

Next earnings

24 Apr 2024

Next Dividend date

12 Jun 2024

Next Ex Dividend date

28 May 2024

Market Stats

By TradingEconomics

Market Cap

-51M

2.8B

Previous open

89.23

Previous close

83.73

News Sentiment

By Acuity

50%

50%

95 / 239 Ranking in Consumer cyclical

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Century Communities Inc chart

Related News

10 Apr 2024, 22:48 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition

10 Apr 2024, 21:40 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.

10 Apr 2024, 21:24 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 20:30 UTC

Top News
Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Investors Await Macquarie's FY 2025 Guidance -- Market Talk

10 Apr 2024, 22:57 UTC

Market Talk

Aussie Banks Unlikely to Get Upgrades Out of Earnings Season -- Market Talk

10 Apr 2024, 21:47 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 21:35 UTC

Top News

Buy the Stock Market's Inflation Freakouts -- Heard on the Street -- Update

10 Apr 2024, 21:09 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B -- Update

10 Apr 2024, 21:05 UTC

Market Talk

Mexican Stocks Close Lower; Peso Weakens Against Dollar -- Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Apr 2024, 20:46 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal -- IBD

10 Apr 2024, 20:28 UTC

Market Talk

Only CPI Surprise, Big-Spending Budget Can Derail Canada Rate Cut in June -- Market Talk

10 Apr 2024, 20:27 UTC

Top News

Hot Inflation Report Weakens Case for Fed's June Rate Cut -- 8th Update

10 Apr 2024, 20:15 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B

10 Apr 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 Apr 2024, 20:08 UTC

Market Talk

SPDR Gold Drops Following Inflation Data -- Market Talk

10 Apr 2024, 20:04 UTC

Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences: Vertex Will Acquire Alpine for $65 Per Shr or Approximately $4.9B in Cash, Transaction Approved by Both Boards of Directors, Anticipated to Close in 2Q >ALPN

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex Subsidiary Will Commence Cash Tender Offer to Purchase All Alpine Common Stk >VRTX

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Alpine Is Strategic Fit and Furthers Use of Scientific Innovation to Create Transformative Medicines Targeting Serious Diseases With High Unmet Need in Specialty Markets >VRTX

10 Apr 2024, 20:02 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Transaction Was Unanimously Approved by Both the Vertex and Alpine Boards

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Will Acquire Alpine for $65 Per Shr or About $4.9 B in Cash >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 19:58 UTC

Market Talk

Markets Largely Ignored BOC's Macklem's Remark on Possible June Cut -- Market Talk

10 Apr 2024, 19:10 UTC

Market Talk

U.S. Natural Gas Futures Eke Out Gains Ahead of Storage Report -- Market Talk

Peer Comparison

Price change

Century Communities Inc forecast

Price Target

By TipRanks

5.04% upside

12 Months Forecast

Average 92.17 USD  5.04%

High 110 USD

Low 82 USD

Based on 4 Wall Street analysts offering 12 month price targets for Century Communities Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

1

Buy

1

Hold

2

Sell

Technical Score

By Trading Central

87.68 / 88.95 Support&Resistance

Short Team

Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

95 / 239 Ranking in Consumer cyclical

News Sentiment

Neutral

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Century Communities Inc

Century Communities, Inc. is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The Company offers attached and detached homes in metropolitan areas in Colorado, Austin and San Antonio, Texas; Houston, Texas; Las Vegas, Nevada, and Atlanta, Georgia. The Company's homebuilding operations are organized into six segments, which include Atlanta, Central Texas, Colorado, Houston, Nevada, and Utah. In many of its projects, in addition to building homes, it is also responsible for the entitlement and development of the underlying land. The Company acquires land for homebuilding operations with the primary intent to develop and construct single family detached or attached homes for sale on the acquired land. It builds and sells a range of home types across a variety of price points. It focuses on assisting homebuyers in obtaining financing by arranging with mortgage lenders to offer qualified buyers a range of financing options.